December 6, 2011 — The radiation oncology department at Addenbrooke's Hospital (Cambridge, United Kingdom) is upgrading its radiotherapy capabilities with Elekta therapy systems, oncology information systems (OIS) and image guided workspace. The two Elekta Synergy image guided radiation therapy (IGRT) systems replace one Siemens and one Varian linear accelerator that had been in service for more than 10 years at the medical center. The facility is run by the Cambridge University Hospitals NHS Foundation Trust.

Officials at Addenbrooke's have been eager to more fully exploit techniques and technologies that modern treatment machines provide, according to Simon Thomas, Ph.D., head of radiotherapy physics. Currently, the medical center treats between 200 and 250 patients each day on seven treatment machines.

"The two capabilities we wanted on the machines were IGRT and VMAT," he says. "IGRT provides images of the target and nearby critical structures we want to avoid - with the patient in the treatment position before therapy. With VMAT, single or multiple radiation beams sweep in uninterrupted arcs around the patient, significantly reducing treatment times."

Acquiring additional IGRT- and volumetric modulated arc therapy (VMAT)-capable treatment machines will enable Addenbrooke's clinicians to offer these imaging and therapy techniques to more patients, Thomas adds.

The hospital asked Elekta and three other providers to submit proposals and give presentations on their equipment to replace the outgoing linear accelerators.

"We compared each company against our clinical and financial requirements and developed an overall score," Thomas says. "Elekta's overall score came out highest, and we combined that with the positive opinions we gathered from other Elekta users in the U.K., and decided to go with Elekta's offerings."

In addition to the Synergy treatment systems, Addenbrooke's acquired the Synergistiq IGRT workspace and the Mosaiq OIS.

For more information: www.elekta.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now